Obesity might not be a risk factor for female sexual dysfunction
Pinar Kadioglu1, Demet Ozgil Yetkin, Oner Sanli
1Department of Endocrinology and Metabolism, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
BJU International
|April 17, 2010
Summary
Obesity does not significantly impact female sexual function (FSD). However, obese women report higher depression levels, which correlate with sexual dysfunction. Hormonal factors, like free testosterone, also showed a negative correlation with sexual function scores.
Area of Science:
- Reproductive Endocrinology
- Obesity Medicine
- Psychiatry
Background:
- Female sexual dysfunction (FSD) is a complex condition.
- Obesity is a growing global health concern with potential impacts on various physiological and psychological aspects.
- Understanding the interplay between obesity, hormonal status, and psychological well-being is crucial for addressing FSD.
Purpose of the Study:
- To investigate the prevalence of FSD in obese women compared to a normal-weight control group.
- To examine the association between obesity, hormonal profiles, and psychological status (depression) in relation to sexual function.
- To identify potential contributing factors to FSD in obese women.
Main Methods:
- A comparative study involving 64 obese premenopausal women and 27 age-matched healthy controls.
- Assessment of sexual function using the Female Sexual Function Index (FSFI) and depression levels via the Beck Depression Inventory (BDI).
- Comprehensive hormonal analysis including reproductive hormones, androgens, and thyroid function tests.
Main Results:
- No statistically significant difference in mean FSFI scores or FSD prevalence between obese and control groups.
- Obese women exhibited significantly higher BDI scores, indicating increased depressive mood.
- Higher BDI scores and lower free testosterone levels were negatively correlated with overall FSFI scores.
Conclusions:
- Obesity itself does not appear to be a direct cause of FSD in this cohort.
- Psychological factors, particularly depression, are significantly associated with sexual dysfunction in obese women.
- While hormonal imbalances were explored, only free testosterone showed a notable negative correlation with sexual function.
Related Concept Videos
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:28Anorexia Nervosa
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...